The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Viral Molecular Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
The global Viral Molecular Diagnostics market size is expected to reach US$ 13090 million by 2029, growing at a CAGR of 7.2% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Molecular Diagnostics in various end use industries. The expanding demands from the Hospitals, Academics Institutions, Laboratories and Others, are propelling Viral Molecular Diagnostics market. Hepatitis B Virus (HBV), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hepatitis C Virus (HCV) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Molecular Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Molecular Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Molecular Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Molecular Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Molecular Diagnostics covered in this report include Abbott Laboraories, Bio-Rad Laboratories, Becton, Dickinson, Roche, Gen-Probe, Qiagen, Olympus and Thermo Fisher Scientific, etc.
The global Viral Molecular Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboraories
Bio-Rad Laboratories
Becton, Dickinson
Roche
Gen-Probe
Qiagen
Olympus
Thermo Fisher Scientific
Global Viral Molecular Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Molecular Diagnostics market, Segment by Type:
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
Human Papillomavirus (HPV)
Global Viral Molecular Diagnostics market, by Application
Hospitals
Academics Institutions
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Molecular Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
The global Viral Molecular Diagnostics market size is expected to reach US$ 13090 million by 2029, growing at a CAGR of 7.2% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Molecular Diagnostics in various end use industries. The expanding demands from the Hospitals, Academics Institutions, Laboratories and Others, are propelling Viral Molecular Diagnostics market. Hepatitis B Virus (HBV), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hepatitis C Virus (HCV) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Molecular Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Molecular Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Molecular Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Molecular Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Molecular Diagnostics covered in this report include Abbott Laboraories, Bio-Rad Laboratories, Becton, Dickinson, Roche, Gen-Probe, Qiagen, Olympus and Thermo Fisher Scientific, etc.
The global Viral Molecular Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboraories
Bio-Rad Laboratories
Becton, Dickinson
Roche
Gen-Probe
Qiagen
Olympus
Thermo Fisher Scientific
Global Viral Molecular Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Molecular Diagnostics market, Segment by Type:
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
Human Papillomavirus (HPV)
Global Viral Molecular Diagnostics market, by Application
Hospitals
Academics Institutions
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Molecular Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Viral Molecular Diagnostics
1.1 Viral Molecular Diagnostics Market Overview
1.1.1 Viral Molecular Diagnostics Product Scope
1.1.2 Viral Molecular Diagnostics Market Status and Outlook
1.2 Global Viral Molecular Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Viral Molecular Diagnostics Market Size by Region (2018-2029)
1.4 Global Viral Molecular Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Viral Molecular Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Viral Molecular Diagnostics Market Size (2018-2029)
1.6.1 North America Viral Molecular Diagnostics Market Size (2018-2029)
1.6.2 Europe Viral Molecular Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Viral Molecular Diagnostics Market Size (2018-2029)
1.6.4 Latin America Viral Molecular Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Viral Molecular Diagnostics Market Size (2018-2029)
2 Viral Molecular Diagnostics Market by Type
2.1 Introduction
2.1.1 Hepatitis B Virus (HBV)
2.1.2 Hepatitis C Virus (HCV)
2.1.3 Human Immunodeficiency Virus (HIV)
2.1.4 Human Papillomavirus (HPV)
2.2 Global Viral Molecular Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Viral Molecular Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Viral Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Viral Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Viral Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Viral Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Viral Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
3 Viral Molecular Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Academics Institutions
3.1.3 Laboratories
3.1.4 Others
3.2 Global Viral Molecular Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Viral Molecular Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Viral Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Viral Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Viral Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Viral Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Viral Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
4 Viral Molecular Diagnostics Competition Analysis by Players
4.1 Global Viral Molecular Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Molecular Diagnostics as of 2022)
4.3 Date of Key Players Enter into Viral Molecular Diagnostics Market
4.4 Global Top Players Viral Molecular Diagnostics Headquarters and Area Served
4.5 Key Players Viral Molecular Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Molecular Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboraories
5.1.1 Abbott Laboraories Profile
5.1.2 Abbott Laboraories Main Business
5.1.3 Abbott Laboraories Viral Molecular Diagnostics Products, Services and Solutions
5.1.4 Abbott Laboraories Viral Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboraories Recent Developments
5.2 Bio-Rad Laboratories
5.2.1 Bio-Rad Laboratories Profile
5.2.2 Bio-Rad Laboratories Main Business
5.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Products, Services and Solutions
5.2.4 Bio-Rad Laboratories Viral Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Laboratories Recent Developments
5.3 Becton, Dickinson
5.3.1 Becton, Dickinson Profile
5.3.2 Becton, Dickinson Main Business
5.3.3 Becton, Dickinson Viral Molecular Diagnostics Products, Services and Solutions
5.3.4 Becton, Dickinson Viral Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Viral Molecular Diagnostics Products, Services and Solutions
5.4.4 Roche Viral Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Gen-Probe
5.5.1 Gen-Probe Profile
5.5.2 Gen-Probe Main Business
5.5.3 Gen-Probe Viral Molecular Diagnostics Products, Services and Solutions
5.5.4 Gen-Probe Viral Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Gen-Probe Recent Developments
5.6 Qiagen
5.6.1 Qiagen Profile
5.6.2 Qiagen Main Business
5.6.3 Qiagen Viral Molecular Diagnostics Products, Services and Solutions
5.6.4 Qiagen Viral Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Qiagen Recent Developments
5.7 Olympus
5.7.1 Olympus Profile
5.7.2 Olympus Main Business
5.7.3 Olympus Viral Molecular Diagnostics Products, Services and Solutions
5.7.4 Olympus Viral Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Olympus Recent Developments
5.8 Thermo Fisher Scientific
5.8.1 Thermo Fisher Scientific Profile
5.8.2 Thermo Fisher Scientific Main Business
5.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Products, Services and Solutions
5.8.4 Thermo Fisher Scientific Viral Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Viral Molecular Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Viral Molecular Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Molecular Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Molecular Diagnostics Market Dynamics
11.1 Viral Molecular Diagnostics Industry Trends
11.2 Viral Molecular Diagnostics Market Drivers
11.3 Viral Molecular Diagnostics Market Challenges
11.4 Viral Molecular Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
